Improving the Accuracy of Referrals of Patients With Chest Pain

NCT04904107 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 852

Last updated 2022-06-10

No results posted yet for this study

Summary

This is a multicenter, prospective, investigator-initiated, randomized controlled trial aiming to reduce the percentage of non-cardiac chest pain (NCCP) patients admitted to the cardiac emergency department (ED) by performing the modified HEART score by emergency medical transport (EMT) personnel.

Conditions

Interventions

DIAGNOSTIC_TEST

modified HEART score (including POC hs cTnI analysis)

The modified HEART score was developed in 2007 and has been validated to stratify the risk of short-term adverse cardiac events in patients with chest pain at the ED. Negative predictive value (NPV) of the modified HEART score for ACS as well as positive predictive value (PPV) for major adverse cardiac events (MACE) within 6 weeks after presentation is high. The modified HEART score is an acronym for history, ECG, age, risk factors and troponin at arrival.The components can be rated 0,1 or 2 points each and result in a total score between 0 and 10.

OTHER

Standard care and triage according to the local (EMT)protocol.

Standard care and triage of chest pain patients according to the local (EMT)protocol.

Sponsors & Collaborators

  • Siemens Healthineers Nederland B.V.

    collaborator UNKNOWN
  • VieCuri Medical Centre

    lead OTHER

Principal Investigators

  • Braim Rahel, Dr. · Viecuri Medical Centre Northern Limburg

  • Joan Meeder, Dr. · Viecuri Medical Centre Northern Limburg

  • Cees de Vos, Dr. · Laurentius Hospital Roermond

  • Arnoud van 't Hof, Prof. dr. · Zuyderland MC

  • Robert Willemsen, Dr. · General practitioner office Nazareth Maastricht

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-04
Primary Completion
2023-06-01
Completion
2024-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904107 on ClinicalTrials.gov